The Latest Cardiac and Vascular News
COTIGNOLA, Italy, Sept. 2, 2020 /PRNewswire/ — Concept Medical Inc., focused on vascular intervention drug delivery devices, has announced the enrolment of the first patient in the TRANSFORM-1 RCT (TReAtmeNt of Small coronary vessels: Randomized controlled trial FOR MagicTouch sirolimus coated balloon). TRANSFORM-1 is a prospective, randomized, multi-center, European study focusing on coronary artery lesions in small vessels with a […]
Proven leader with over 30 years of success developing novel medical devices PRAIRIE VILLAGE, Kan., Sept. 1, 2020 /PRNewswire/ — Artio Medical, Inc. (Artio), a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, today announced it has named Paul Muller to serve as Chief Technology Officer (CTO) and General […]
The ECG Holter agreement marks the launch of Cardiologs’ AI-based cloud technology business operations in Europe to detect cardiac rhythm disorders BOSTON, Sept. 1, 2020 /PRNewswire/ — Cardiologs, a global leader in artificial intelligence (AI) cardiology diagnostics, today announced an exclusive distribution agreement in France with MicroPort CRM, for the reselling of its cloud analysis solution […]
AUSTIN, Texas, Aug. 31, 2020 /PRNewswire/ — Physicians with the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center are among the first in the world to participate in a clinical trial to evaluate a new intra-cardiac echocardiography catheter. Andrea Natale, M.D., F.H.R.S., F.A.C.C., F.E.S.C., cardiac electrophysiologist and executive medical director of TCAI, and Amin Al-Ahmad, […]
OXFORD, England, Sept. 1, 2020 /PRNewswire/ — GEN inCode UK Limited, the privately-owned artificial intelligence cardiovascular disease company focused on the prevention of cardiovascular disease, announces today the completion of a £3.0M institutional fundraise to internationally scale its products and technology. GEN inCode specializes in genetic risk assessment and the prediction of cardiovascular […]
– Provides patients suffering from peripheral vascular diseases a safer and more effective treatment than traditional balloon angioplasty – DCB to become the future standard of care for superficial femoral artery treatment – Fast growing global market with estimated 13% CAGR, to reach around US$1billion by 2025 SINGAPORE, Aug. 31, 2020 /PRNewswire/ […]
Award reflects excellence in visionary innovation, performance, and customer impact MINNEAPOLIS, Sept. 1, 2020 /PRNewswire/ — Preventice Solutions, a leader in digital healthcare solutions and remote cardiac monitoring services powered by deep learning and artificial intelligence (AI), announced today it received the 2020 Frost & Sullivan Global Remote Cardiac Monitoring Company of the […]
EDEN PRAIRIE, Minn., Sept. 01, 2020 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, announced today receipt of written notification from the Nasdaq Stock Market that it has granted the company’s request for an 180-day extension […]
VANCOUVER, British Columbia, Aug. 31, 2020 (GLOBE NEWSWIRE) — Novoheart Holdings Inc. (“Novoheart” or the “Company”) reports financial results for the three and six months ended June 30, 2020. Amounts, unless specified otherwise, are expressed in Canadian dollars and are in accordance with International Financial Reporting Standards (IFRS). Business Highlights: […]
Technology Revenues Surged in the Quarter Ended June 30, 2020 REDWOOD CITY, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced record results in its technology service revenues, demonstrating a continued pattern of improved growth for its first […]
